NCT04980287Recruiting
Mesogastrium Metastasis in Colon Cancer
Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 20 Jul 2021
- Start date
- 12 Jan 2021
- Primary completion date
- 19 Jul 2025
- Lead sponsor
- Jichao Qin
- Diseases
- Colorectal cancer
- NCT number
- NCT04980287
What you commit to
- Study type: Observational
- Planned participants: 50
- From 12 Jan 2021 to the primary completion date, 19 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of colorectal cancer or other malignant tumors
Other
- Synchronous colorectal carcinoma
- Clinical evidence of metastasis
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Who the study is looking for
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- tumor located at hepatic flexure or transverse colon close to flexures
- Undergoing complete mesocolic excision with right gastric mesentery resection
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Coordinator of this site? Confirm its status | Wuhan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.